SyntekaBio Registered Director Hong Jong-hee Increases Stake from 0.35% to 0.54% via Open Market Purchase

SyntekaBio registered director Hong Jong-hee acquired an additional 44,693 common shares on June 30, 2026 through open market purchase, increasing his holdings from 85,703 to 130,396 shares.
The acquisition price was 1,574 KRW per share, raising his ownership ratio from 0.35% to 0.54%.
This transaction represents a personal investment by an insider and does not affect the company's capital structure or cause any dilution.
[AI Summary]The insider's open market purchase may be interpreted as a positive signal of management confidence, but the small scale limits direct impact on the stock price. SyntekaBio's current price is 1,503 KRW, slightly below the acquisition price, with no other significant corporate changes.